SXTP PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

SXTP ▼ -18.40% at T+20d

NEUTRAL call ✗ call lost -18.40% · α vs SPY -24.44% · entry $2.12 → $1.73

Next anchor: T+60d in 2d

Last close $1.43 (close Jun 8) · -32.55% from $2.12 entry

Entry anchored
Mar 17, 03:59 PM ET
via Databento tick

T+1d

-8.96%

call -8.96% · α -8.70%

$1.93

settled 3mo ago

T+5d

-26.89%

call -26.89% · α -26.17%

$1.55

settled 3mo ago

T+20d

-18.40%

call -18.40% · α -24.44%

$1.73

settled 8w ago

T+60d

—

call — · α —

—

in 2d

Price Chart

Loading chart...

Executive Summary

Sixty Degrees Pharmaceuticals submitted a New Dietary Ingredient Notification (NDIN) to the FDA for a dietary supplement containing Australian Chestnut Extract, with no objection period ending May 25, 2026. The company also secured an option to license a new capsule formulation from Florida State University, expanding its earlier license for large-scale purification of castanospermine.

Actionable Insight

Monitor FDA non-objection status by May 25, 2026 — a green light could enable near-term commercialization of a dietary supplement, providing early monetization of castanospermine. However, given the company's going-concern uncertainty and lack of manufacturing capacity, any commercial impact remains speculative.

Key Facts

Submitted NDIN to FDA for Australian Chestnut Extract on March 11, 2026
FDA has until May 25, 2026 to object; no objection allows marketing
Signed option agreement with Florida State University to license capsule formulation technology
Expanded on January 2026 license for large-scale purification of castanospermine
Castanospermine is the active constituent and has prior human safety data via celgosivir trials

Financial Impact

No immediate financial impact disclosed; potential long-term revenue if commercialized

revenueR&D pipeline

Risk Factors

FDA may object to the NDIN before May 25, 2026
Company has substantial doubt about its ability to continue as a going concern
No manufacturing capacity — reliant on third parties for production

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3258123

4 reports for SXTP

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for SXTP — sortable, filterable
	Type				Now
May 26, 2026 14d ago	Press Release NEUTRAL ★ 4/10	$1.50 $1.46	▼ −2.67%	▼ −3.75%	$1.43 (−4.67%)
May 15, 2026 25d ago	Press Release BEARISH ★ 6/10	$1.39 $1.48	▼ −6.47%	▼ −5.51%	$1.43 (−2.88%)
Mar 31, 2026 10w ago	Press Release MIXED ★ 5/10	$1.75 $1.81	▲ +3.43%	▼ −0.52%	$1.43 (−18.29%)
Mar 18, 2026 11w ago	Press Release NEUTRAL ★ 4/10	$2.12 $1.55	▼ −26.89%	▼ −26.17%	$1.43 (−32.55%)

US Market Status

Market Closed — Opens in 8h 36m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access